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組 橋 由 記２１０
The role in cancer therapy of “a board certified oncology pharmacy specialists”
Yuki Kumihashi
Department of Pharmacy, Tokushima Red Cross Hospital, Tokushima, Japan
SUMMARY
A Board Certified Oncology Pharmacy Specialists（BCOPS）system was started in 2006.
BCOPS should be used to support many chemotherapy regimens and the management of their
adverse effects, because cancer chemotherapy has become quite complicated as a result of its rapid
development.
A law governing cancer treatment was passed in 2007. According to this law, medical institu-
tions are required to give all cancer patients the best treatment and care. BCOPS can help institu-
tions meet this requirement. Today, BCOPS are expected to have areas of special expertise. For
example, BCOPS understand treatment guidelines and can join in a discussion of the treatments as
experts on medicines, in particular the medicines used in cancer treatment. BCOPS must work to
avoid adverse effects, improve quality of life and provide palliative care for patients. Therefore, as
much knowledge and experience as possible should be represented on multidisciplinary care teams.
Also, it is important that information on patients is shared with staff members in various roles,
and that team members work in close cooperation with each other. BCOPS should be involved
with patients as members of multidisciplinary care teams.
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